Prestige Wealth Management Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Prestige Wealth Management Group’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-978	Closed	–	–	666
2019 Q2	$0	Hold	978	–	–	﹤0.01%	521
2019 Q1	$5K	Sell	978 -500	-34%	-$2.37K	﹤0.01%	412
2018 Q4	$5K	Buy	+1,478	New	+$10.3K	﹤0.01%	622

Prestige Wealth Management Group's INSY Position: Q3 2019 in Review

Prestige Wealth Management Group sold out of Insys Therapeutics, Inc. (INSY) in Q3 2019, closing a stake of 978 shares.

Prestige Wealth Management Group first reported a position in INSY in Q4 2018 and held it in 3 quarters. The position peaked at $5K in Q1 2019. 4 funds tracked by Wall St. Rank hold INSY as of Q3 2019.

Prestige Wealth Management Group reported no remaining Insys Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Prestige Wealth Management Group sold 978 Insys Therapeutics, Inc. shares in Q3 2019.
Prestige Wealth Management Group first reported a position in Insys Therapeutics, Inc. in Q4 2018 and held it in 3 quarters.
Prestige Wealth Management Group's Insys Therapeutics, Inc. position peaked at $5K in Q1 2019.
4 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2019.

Based on Prestige Wealth Management Group's 13F filing for Q3 2019, filed 14 Nov 2019.